You have no items in your shopping cart.
You have no items in your shopping cart.
Catalog Number | orb1805472 |
---|---|
Category | Antibodies |
Description | Anti-ERBB2 / HER2 / CD340 Reference Antibodyonomethyl auristatin E (MMAE). Disitamab vedotin targets HER2 protein on tumors, recognizes and penetrates cancer cells with high precision, and releases the small molecule cytotoxic drug to kill the cancer cell. The ADC is used for the study of various cancers. |
Target | ERBB2 / HER2 / CD340 |
Clonality | Recombinant |
Conjugation | MMAE |
Reactivity | Human |
Concentration | 1 mg/mL |
Buffer/Preservatives | 100 mM Proline/Acetic acid 20mM Arginine pH 5.0 |
Purity | > 95% |
Purification | Protein A |
UniProt ID | P04626 |
MW | 149.2 kDa |
Tested applications | ELISA, FA, FACS, In vivo |
Antibody Type | Recombinant Antibody |
Expression System | CHO |
Endotoxins | < 0.001 EU/ug |
Storage | Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Note | For research use only |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (disitamab vedotin) on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95%.
The purity of Anti-ERBB2 / HER2 / CD340 Reference Antibody (disitamab vedotin)is more than 98.7% ;determined by SEC-HPLC.
ELISA, FC | |
Human | |
Monoclonal | |
Unconjugated |
ELISA, FA, FACS, In vivo | |
Human | |
Recombinant | |
MMAE |